Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib
Crossref DOI link: https://doi.org/10.1007/s00228-016-2017-1
Published Online: 2016-02-09
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Small, David S.
Zhang, Wei
Royalty, Jane
Cannady, Ellen A.
Downs, Delyn
Ortega, Demetrio
Suico, Jeffrey G.
Funding for this research was provided by:
Eli Lilly and Company
License valid from 2016-02-09